INTRODUCTION
Most studies on the effects of lead on the peripheral nerves used 'current' blood lead levels of the workers and infer the nerve conduction's findings to it. This practice is not ideal as the toxicity of lead on the peripheral nerves occurs over a period of time. Seventy-two workers in a lead battery manufacturing factory and 82 referents were studied with the aim of (1) correlating the nerve conduction parameters of the median and ulnar nerves of the dominant forearms with the blood cumulative lead-years (BPbCum) results; (2) determining a 'noeffect' cumulative dose of lead on the peripheral nerves. The mean BPb for the exposed and referent were 36.9ng/100ml and 10.5ng/100ml, respectively. The mean BPbCum was 136.8 (range=6.7-1087.0)u.g-year/100ml. Significant differences were found in the adjusted (for age, ethnical groups, smoking and drinking habits by ANCOVA) means median sensory conduction velocity, motor conduction velocity, distal latency and amplitude between the exposed and referent groups. But for the ulnar nerve only, distal latency was significantly different. With the BPbCum groups, dose response relations are noted in both the nerve conduction parameters of the median and ulnar nerves. There were no significant differences for the ulnar and median nerves conduction parameters between BPbCum <40|ig-year/100ml group and referent. Based on the study's findings, it would suggest that a maintained blood lead level of less than 40ug/100ml for one year may not have significant effects on the median and ulnar nerves. Recent studies of the peripheral nerves in workers exposed to lead have used electrophysiological probes to determine whether lead causes definite abnormalities in function.
In the first of these studies Seppalainen et al. 1 found evidence for asymptomatic slowing of motor nerve conduction velocity in workers whose blood lead concentrations had never exceeded 70n.g/dl. Seppalainen et al. 2 in a further study found that ulnar nerve conduction velocity was depressed at blood lead concentrations below 50ug/dl. More recently, Seppalainen et al. 3 reported slowing of ulnar nerve conduction velocity at blood lead concentration as low as 30ug/dl. However, Seppalainen's findings were not consistent with other reports. Triebig et al. 4 studied 148 male workers who were exposed to lead from the manufacture of storage battery and 66 male controls. Statistically significant differences for nerve conduction velocities were seen only for distal sensory nerve of the ulnar and median nerves. The authors concluded that at blood lead concentrations below 70ug/dl, no functionally significant lead-induced reduction of nerve conduction velocity is to be expected.
Jeyaratnam et al. s reported mean maximum motor conduction velocities of the median nerve was significantly lower in the workers exposed to lead (mean blood lead of 48.7ug/100ml) than controls (mean blood lead of 15.8ug/100ml).
Other studies 6 ' 7 have also reported reduction in peripheral nerve conduction velocities in workers exposed to lead. In fact, the US Environmental Protection Agency reported that motor nerve dysfunction, assessed by electrophysiological measurement of nerve conduction velocities, has been shown to occur with blood lead levels as low as 40ug/100ml. 8 However, most of the quoted studies used 'current' blood lead levels of the workers and infer the nerve conduction's findings to it. This practice is not ideal as the toxicity of lead on the peripheral nerves occurs over a period of time.
The objectives of this study are: (1) to study the nerve conduction parameters of a group of lead exposed workers and correlate it with the blood cumulative lead-years results; (2) to determine a 'noeffect' cumulative dose of lead on the peripheral nerves.
MATERIALS AND METHODS

Study subjects
The exposed population consisted of 72 workers from a lead battery manufacturing factory. The workers are involved in smelting of lead ingots, lead pasting, forming, assembling and welding of the battery connectors. The workers are usually rotated through these various sections and had considerable exposure throughout their working life.
The non-exposed (referent) group consisted of 82 factory workers who were undergoing pre-employment medical examination. None of referent group had any significant history of exposure to lead or any known neurotoxic substances.
The subjects were selected by the following criteria: (1) no history of any metabolic diseases, e.g. diabetes mellitus, thyrotoxicosis, etc; (2) clinically normal and (3) no alcoholic consumption of more than 50g of alcohol per day.
Biological measurements
A blood sample was obtained by venepuncture with lead-free disposable syringes and stored in lead-free bottles. Blood lead (BPb) was determined using an atomic absorption spectrophotometer with a granite furnace. External quality control was carried out under the Quality Assessment Scheme (NEQAS) in the UK. Table 1 shows the accuracy in determination of BPb since 1985.
Concentrations of BPb had been measured every 6 months since 1982 for this factory. Past records of BPb were available for 61 out of 72 exposed workers. As an index of the body burden of lead, a cumulative blood index (BPbCum) was computed for each worker by calculating the area under the curve of BPb against time with the formula:
where BPbi and BPb i+ i are the i lh and (i+l) th BPb readings and ti+i -U is the period between the two readings. Among the longer serving exposed workers, there were no pre-employment BPb determinations or regular periodic examinations in the early years. For these workers, the first available BPb reading was linearly extrapolated backwards to a pre-employment level of 10.5ng/100ml. The concentration of 10.5ug/100ml was chosen because this was the mean BPb value of the referent group. Thus, for example, a BPbCum of 60ug-years/100ml could be obtained from one year with a blood lead of 60ug/ 100ml or 6 years at a blood lead level of 10ug/100ml.
Nerve conduction methods
Nerve conduction studies were performed by a trained technician from a neurology laboratory for each subject. Measurements were made with a Medelec electrophysiological system (Model MS6) with two channels averaging facilities. Tracing were recorded on light sensitive paper. The room temperature was maintained constantly at 30°-31°) C and skin impedance was kept below 10 Kohms for all recordings.
Maximum motor conduction velocity (MMCV) and distal motor latency of the median and ulnar nerves were determined in the dominant forearm. The median nerve was stimulated at the wrist (13cm from the base of the forefinger) and at the elbow. The MMCV and distal latency of the ulnar were obtained by stimulation at the lateral aspect of the wrist (10 cm from the base of the little finger) and just below the medial epicondyle. The muscle action potential of the thenar (for median nerve) and hypothenar (for ulnar nerve) muscles were recorded with surface disc electrodes.
The median maximum sensory nerve conduction velocity (MSCV) was measured by stimulating the forefinger with ring electrodes and recording orthodromically at the wrist (13cm from the base of the forefinger). The ulnar conduction velocity was recorded by stimulating the little finger with ring electrodes and recording orthodromically at the lateral aspect of the wrist (10cm from the base of the little finger). 
Statistical analysis
The distribution of the nerve conduction parameters, BPb, and BPbCum were highly skewed. Logarithmic transformation was used to normalize the distribution. To assess the dose-effect relation of various categories of BPbCum, the mean nerve conduction parameters were compared between groups after adjustment for age, ethnic groups, smoking and drinking habits by analysis of covariance (ANCOVA).
RESULTS
Study population
No marked differences were noted in the age and alcohol intake of the exposed and reference subjects ( Table 2 ). There is a higher percentage of Malay and smokers among the referent group. The mean BPb for the referent group was 10.5 (range=4.4-19.8) ug/100ml. The mean duration of exposure for the exposed workers was 5.3 (range<l-19.8) years. The mean current concentration of BPb was 36.9 (range=7.3-68.5)ug/100ml. The mean BPbCum was 136.8 (range=6.7-1087.0)ug-year/100ml.
Indices of exposure and effects on nerve conduction
The effect of age as an effect modifier on the nerve conduction parameters for the exposed workers was tested by dividing the subjects into two age groupings. Age of the exposed was not a significant effect modifier. There were significant differences in all the means median nerve conduction parameters of the dominant forearm viz. sensory conduction velocity, motor conduction velocity, distal latency and amplitude between the exposed and referent groups. This was true even after adjustment for age, ethnic groups, smoking and drinking habits by ANCOVA (Table 3 ). The ulnar nerve conduction parameters for the exposed were not significantly different from the referents', except for the distal latency. Figure 1 shows the distribution of blood lead levels of each worker over the years for which the results are available. Except for five workers, none of the workers' blood lead exceeded 70ug/dl throughout their exposure duration.
No significant correlation was obtained with BPb and BPbCum levels against the nerve conduction parameters using multiple linear regression after adjusting for age, ethnic groups, smoking and drinking histories. With the BPbCum groups, dose-response relations are noted in both the nerve conduction parameters of the median and ulnar nerves (Table 4) . Current BPb levels, grouped into different categories, however, did not show any definite trends against the nerve conduction parameters.
DISCUSSION
The mean BPb for the exposed was 36.9 ug/lOOml. At this level, significant differences where observed for all the median nerve conduction parameters of the exposed compared with the referents. Interestingly, there was no significant difference of the ulnar nerves conduction parameters between the exposed and referents (except for distal latency). The median nerve appears to be more susceptible to lead effects than the ulnar nerve. In a review article by Ehle 9 on electrophysiological studies in low level lead exposure there were seven reports where both the median and ulnar nerves were studied. Of these seven reports, five (71%) had significant slowing of the median nerve conduction velocities only. Four (57%) of the seven studies reported involvement of the ulnar nerves (all had concomitant significant slowing of the median nerves conduction velocities).
In the present study, the distal latency was used as a measure to detect early changes and proved to be a sensitive indicator. Since exposure to lead is known to cause axonal degeneration 9 in addition to segmental demyelination, 10 neurophysiological measurements on the distal segments of the peripheral nerves are likely to show the earliest changes in lead neuropathy, and this makes the measurement of the distal latency a useful test with which to detect early neurological abnormalities in lead workers. Although there were no differences in the other exposed's nerve conduction parameters for the ulnar nerve compared with the referents, the distal latency was significantly prolonged.
If nerve conduction is to be used a part of a medical surveillance for workers exposed to lead, and only a peripheral nerve is to be studied, the median nerve would be the best choice. Distal latency, where possible, should be included as it detects early abnormalities before the other parameters are abnormal. Peripheral neuropathy caused by lead is usually associated with chronic lead exposure rather than acute, unless the exposure is very high. Thus it would be more objective to look at cumulative blood lead level rather than current blood values to determine the effect of lead on the peripheral nervous system.
Balbus-Kornfeld et a/." in a recent epidemiological review on cumulative exposure to inorganic lead and neurobehavioural test performance in adults has highlighted the usefulness of BPbCum (the area under the curve) as a measure of cumulative exposure. In fact, BPbCum has been shown to correlate highly with bone lead as measured by X-ray fluorescence. 12 Recent studies of X-ray fluorescence of lead in bone have indicated that this measurement may be a good indicator of body burden of lead.
l3 Although, the BPbCum denotes the cumulative lead burden on the body, it must be noted that it may not reflect the peaked exposures during the period of work in lead environment. In the context of this study, peaked exposures effects may not be very significant as most of the workers had blood level of <70ug/dl (Figure 1 ). At present mean cumulative blood lead level of 136.8ug-year/100ml, the exposed had significantly poorer median sensory and motor conduction velocities, median distal latency and amplitude compared to the referent. We were not able to derive a significant linear correlation of the nerve conduction parameters with the BPb or BPbCum. This was in agreement with the review paper by Ehle:
9 'it would appear from review of all the studies of blood lead levels vs. nerve conduction velocity that the majority of studies do not support a continuous linear relationship between blood lead and nerve conduction velocity in adults at blood levels below 70ug/100ml.' The reason why most studies did not obtain a continuous linear relationship could be that the effect of lead on the peripheral nerve may not be linear. Animal studies involving dosing rats with lead suggest that effect of lead on the peripheral nerves is not linear. 13 Of course, difference between species (animals vs. human) makes generalization of any data obtained from animals difficult.
The BPbCum levels were grouped into various categories in an attempt to determine a 'no-effect' cumulative blood lead level. At BPbCum of <40ug-year/100ml there were no significant differences between all the exposed nerves (median and ulnar) conduction parameters and the referents'. However, it must be noted that the actual number of workers with BPbCum of <40u.g-year/100ml was only 12. The small number itself may have reduced the power of the analysis. At BPbCum of <50ug-year/ 100ml (w=14), significant differences were noted in some of the exposed nerve conduction parameters compared to the referents. Based on the study's findings, it would suggest that a worker with a maintained blood lead level of less than 40ug/ 100ml for one year may not have significant effects on the median and ulnar nerves. However, we would like to caution further interpretation of the present BPbCum results. For example, BPbCum of 50u.g-year/ 100ml does not imply that 10 years exposure at a blood lead level of 5u.g/100ml would affect nerve conduction. All the workers' blood lead level were more than 5ug/100ml even before exposure to lead. In fact, a majority of the exposed workers had blood lead of more than 40ug/100ml at some point in time during the examination. More work needs to be done in this area to establish a more definite 'no effect' blood lead level on the peripheral nerve over time. But in the light of our study's findings and that of others 8 it would be prudent to keep the blood lead levels below 40u.g/ 100ml to avoid the effects of lead on the peripheral nerves.
